JFL
EW icon

Jarislowsky, Fraser Ltd’s Edwards Lifesciences EW Stock Holding History

Jarislowsky, Fraser Ltd’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,794
Closed -$232K – 212
2021
Q4 		$232K Hold
1,794
– – ﹤0.01% 209
2021
Q3 		$203K Buy
+1,794
New +$205K ﹤0.01% 214
2021
Q1 		– Sell
-3,306
Closed -$301K – 225
2020
Q4 		$301K Hold
3,306
– – ﹤0.01% 203
2020
Q3 		$263K Hold
3,306
– – ﹤0.01% 196
2020
Q2 		$228K Hold
3,306
– – ﹤0.01% 199
2020
Q1 		$207K Buy
3,306
+57
+2% +$4.11K ﹤0.01% 204
2019
Q4 		$252K Buy
+3,249
New +$254K ﹤0.01% 217

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jarislowsky, Fraser Ltd's EW Position: Q1 2022 in Review

Jarislowsky, Fraser Ltd sold out of Edwards Lifesciences (EW) in Q1 2022, closing a stake of 1,794 shares — an estimated $232K sold.

Jarislowsky, Fraser Ltd first reported a position in EW in Q4 2019 and held it in 7 quarters. The position peaked at $301K in Q4 2020. 1,312 funds tracked by Wall St. Rank hold EW as of Q1 2022.

  • Jarislowsky, Fraser Ltd reported no remaining Edwards Lifesciences position as of Q1 2022 after selling out during the quarter.
  • Jarislowsky, Fraser Ltd sold 1,794 Edwards Lifesciences shares in Q1 2022, an estimated $232K.
  • Jarislowsky, Fraser Ltd first reported a position in Edwards Lifesciences in Q4 2019 and held it in 7 quarters.
  • Jarislowsky, Fraser Ltd's Edwards Lifesciences position peaked at $301K in Q4 2020.
  • 1,312 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2022.

Based on Jarislowsky, Fraser Ltd's 13F filing for Q1 2022, filed 12 May 2022.